COMMUNIQUÉS West-GlobeNewswire

Affordable Pet Labs Launches Nationwide Validation Study of an At-Home Heartworm Test, and Invites Dog Owners in 52 Cities to Help
26/10/2026
More than 1,500 dogs will receive a complete heartworm test from a visiting APL technician at no cost. If the new method meets the current gold standard, APL plans to bring it to pet parents nationwide, direct to [...]
Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity
26/10/2026
New wholly owned subsidiary, led by Adrian Jones, to expand the Company's network of clinics and pharmacies across Australia VANCOUVER, British Columbia, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: [...]
BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop
26/10/2026
CARSON CITY, Nev., Oct. 26, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases [...]
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
26/10/2026
Amy Rock, Ph.D., appointed Chief Regulatory and Quality Officer, bringing extensive experience in global regulatory strategy, clinical development, and with approvals of novel immunotherapies Dae Gon Ha, Ph.D., [...]
TransCon® PTH (Palopegteriparatide) Demonstrates Sustained, Clinically Meaningful Improvements in Kidney Function in Adults with Hypoparathyroidism Treated Up to 5 Years
26/10/2026
COPENHAGEN, Denmark, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data demonstrating early, sustained, and clinically meaningful improvements in kidney function in adults with [...]
Novastra Therapeutics Reports Encouraging First Clinical Data for Its Novel XIRT™/OAP Cancer Immune Therapy at ESMO Congress 2026
26/10/2026
Initial data from an investigator-initiated Phase 1 study provide early proof of concept for systematic immune reprogramming therapy (XIRT™) XIRT is built on Novastra’s proprietary OmniAntigen™ Platform (OAP) designed [...]
Oncotelic Announces PDAOAI Identification of a Four-Gene Liver Cancer Signature
26/10/2026
Study combines AI-guided literature investigation with gene-expression analysis to identify a four-gene signature for Sapu003 development Source: Oncotelic Therapeutics, Inc. AGOURA HILLS, Calif., Oct. 26, 2026 (GLOBE [...]
Seismic Therapeutic to Participate in Upcoming Investor Conferences
26/10/2026
WATERTOWN, Mass., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Seismic Therapeutic, Inc. today announced that company management will participate in the following investor conferences: Stifel 2026 Healthcare Conference Date: [...]
Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026
26/10/2026
RADNOR, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2026 [...]
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
26/10/2026
SAN FRANCISCO, CALIFORNIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company [...]
Stryker completes acquisition of ZuriMED to enhance its shoulder offering
26/10/2026
Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Stryker has completed its acquisition of ZuriMED, adding the FiberLocker System to its Sports Medicine portfolio The acquisition adds a commercialized rotator cuff [...]
Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component
26/10/2026
First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028 Built on the proven sensing technology behind [...]
Major shareholder announcement
26/10/2026
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis has received a major shareholder notification from BlackRock, Inc. regarding its holdings in Novonesis. As of October 21, 2026, BlackRock, Inc.’s [...]
Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas
26/10/2026
Single-agent NXP200 was administered to 27 patients with recurrent or progressive gliomas (20 with high-grade and 7 with low-grade). The objective response rate (ORR) based on Response Assessment in Neuro-Oncology [...]
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
26/10/2026
Topline Phase 1 proof-of-mechanism data anticipated in Q2 2027 Randomized, double-blind, placebo-controlled study will evaluate safety, tolerability, PK and PD of EQ504 Triggers Milestone Closing of $20 million in [...]
Weight Watchers Schedules Third Quarter 2026 Earnings Conference Call
26/10/2026
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”) will release its results for the third quarter 2026 ended September 30, 2026, before market open on [...]
CytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026
26/10/2026
Phase 2 CLOVER study enrolled 66 patients across seven sites in metastatic colorectal cancer Updated data show universal CCR5 expression, early ctDNA reductions and favorable tolerability VANCOUVER, Washington, Oct. 26 [...]
SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences
26/10/2026
FORT LAUDERDALE, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII) , a developer of innovative surgical robotic technologies [...]
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
26/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum